Home / CTNNAL1 Knockout Cell Lines

CTNNAL1 Knockout Cell Lines

Gene: CTNNAL1

Official Full Name: catenin alpha like 1provided by HGNC

Gene Summary: Predicted to enable actin filament binding activity and cadherin binding activity. Acts upstream of or within Rho protein signal transduction. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO33912 CTNNAL1 Knockout cell line (HeLa) Human CTNNAL1 1:3~1:6 Negative Online Inquiry
KO33913 CTNNAL1 Knockout cell line (HCT 116) Human CTNNAL1 1:2~1:4 Negative Online Inquiry
KO33914 CTNNAL1 Knockout cell line (HEK293) Human CTNNAL1 1:3~1:6 Negative Online Inquiry
KO33915 CTNNAL1 Knockout cell line (A549) Human CTNNAL1 1:3~1:4 Negative Online Inquiry

Background

CTNNAL1 Gene Knockout Cell Lines are engineered cellular models specifically designed to investigate the role of the CTNNAL1 gene in various biological processes and diseases. These knockout cell lines are created through advanced CRISPR/Cas9 technology, which facilitates precise gene editing to abrogate the expression of the CTNNAL1 gene. By removing this gene, researchers can explore its contributions to cellular dynamics, signaling pathways, and its involvement in conditions such as cancer, neurological disorders, and developmental abnormalities.

The key functionality of these cell lines lies in their ability to provide a controlled environment for studying the effects of CTNNAL1 deficiency. By examining cellular behavior in the absence of this gene, scientists can elucidate the underlying molecular mechanisms and interactions that are typically obscured in wild-type cells. This targeted approach significantly enhances the understanding of gene function and its broader implications in health and disease.

The scientific importance of CTNNAL1 Gene Knockout Cell Lines is underscored by their applications in both basic research and translational studies. These models are invaluable for drug screening, validation of therapeutic targets, and facilitating personalized medicine approaches. Researchers can efficiently assess the efficacy of novel compounds against disease models devoid of CTNNAL1, thus streamlining the drug discovery process.

What sets our CTNNAL1 Gene Knockout Cell Lines apart from alternatives is their comprehensive validation and consistent performance across diverse applications. This product is backed by robust characterization data, ensuring high specificity and reproducibility, which researchers desire for reliable outcome generation. Unlike traditional methods, our knockout lines offer a more straightforward and efficient pathway for studying gene function without the confounding effects of other genetic factors.

For researchers and clinicians, investing in CTNNAL1 Gene Knockout Cell Lines means gaining access to a tool that enhances experimental rigor and supports innovative explorations in gene function. Our commitment to quality and customer support distinguishes us as a leading provider in genetic research products. By choosing our offering, you are backed by a company renowned for facilitating cutting-edge research, ensuring you achieve your scientific goals with confidence.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.